Abstract
dc:description.abstractStroke is one of the leading causes of death and disability worldwide. Advances in hyperacute treatments for ischaemic stroke, such as thrombectomy and thrombolysis, have increased the number of individuals surviving stroke. Nevertheless, many survivors will continue to experience both neurological and non-neurological complications throughout the rest of their lives. Improving functional outcomes in stroke patients has therefore become a major research priority. An often-underrepresented component of recovery are the systemic complications of stroke. The lungs and gut are two key peripheral sites which experience stroke-related complications and in turn modify neurological recovery via the lung-gut-brain axis. The functional capacity of the systemic immune system is impaired acutely after stroke, which contributes to these complications. Disruption of homeostasis and/ or infection at these sites have been associated with poorer health outcomes in stroke survivors. Despite this, there is limited understanding of these alterations beyond the acute recovery period, or of the mechanisms by which they alter neurological recovery. Stroke-associated pneumonia is experienced by up to 30 % of stroke patients during acute recovery and significantly worsens clinical outcomes. Here, an animal model of ischaemic stroke has been used to investigate the impact of respiratory bacterial challenge on recovery. Endotracheal inoculation with Streptococcus pnemoniae two weeks after stroke was used to model sub-acute respiratory infections. Stroke resulted in a reduced ability to clear lung bacteria and evidence of functional immune deficits. Despite this, respiratory challenge exacerbated inflammation both in the lung and the recovering brain. Similarly, in the gut, alterations to the composition of the microbiome after stroke has been shown in both human and animal models to impact neurological outcomes. Furthermore, many patients experience prolonged gastrointestinal dysfunction, including dysphagia and constipation which are also associated with an increased risk of infection, mortality, and a second ischaemic incident. Again, there is limited data which describes changes to intestinal homeostasis beyond acute stroke recovery. Here, characterisation of structural, functional and immune environments of the gut out to three months post-stroke demonstrated prolonged changes to gut homeostasis which evolved across recovery showing distinct acute and chronic profiles. While reductions in mucus production, gut transit time and faecal cytokine levels resolved after the acute recovery timepoint, structural changes to the colon persisted into acute recovery. These crucial data, provide information on the longitudinal effects of stroke on the lung and gut microenvironments and illustrate how complications, such as respiratory bacterial infection, impact the recovering brain. Investigating systemic changes beyond the acute recovery period has provided targets for further investigation into the bi-directional communication between the recovering brain and systemic organs and opportunities for intervention.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Martin, Rachel
- Advisors dc:contributor.advisor
-
- McCulloch, Laura
- Dockrell, David
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7183